Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06696521 · ClinicalTrials.gov registry record · NA
An Analysis of Medication Adherence Using Televideo and Telephonic Monitoring and Utilization of an Education Protocol
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT06696521 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 76 participants.
The verdict
NCT06696521, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate adherence to oral oncologic medication regimens utilizing a standardized education tool to explain the dosing, side effects and purpose of oral chemotherapy via televideo or telephonic interactions. Researchers aim to evaluate whether the modality of education and monitoring impact adherence.
Interventions
- BEHAVIORAL Intervention A- Telephone
- BEHAVIORAL Intervention B- Televideo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2025-02-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06696521
The ClinicalTrials.gov registry entry for NCT06696521 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intervention A- Telephone is the first listed.
NCT06696521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06696521 about?
NCT06696521 is a clinical study titled "An Analysis of Medication Adherence Using Televideo and Telephonic Monitoring and Utilization of an Education Protocol". The objective of this study is to evaluate adherence to oral oncologic medication regimens utilizing a standardized education tool to explain the dosing, side effects and purpose of oral chemotherapy via televideo or telephonic interactions. Researchers aim to evaluate whether the modality of educat...
What is the current status of trial NCT06696521?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2021-02-09. Estimated completion is 2025-02-11.
What interventions are being tested in trial NCT06696521?
The interventions under investigation include: Intervention A- Telephone (BEHAVIORAL), Intervention B- Televideo (BEHAVIORAL).
Who is sponsoring clinical trial NCT06696521?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.